BSBaruch Spivak

Baruch Spivak

*This is an algorithmically generated author record based on publicly available information.

Baruch Spivak has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Effects of Clozapine Versus Haloperidol on Measures of Impulsive Aggression and Suicidality in Chronic Schizophrenia Patients

    by Baruch Spivak, Evgeny Shabash, Brian Sheitman, Abraham Weizman, Roberto Mester

    The risk of suicide for schizophrenia patients is 20 to 50 times higher than that for the general population. Long-term treatment with clozapine, an atypical antipsychotic, has been shown to reduce the rate of suicide by 80% to 85%. The goal of the present study was to examine whether clozapine's effect on the reduction of suicidal behavior in chronic schizophrenic patients could be due to a reduction in impulsive-aggressive behavior. 44 patients with chronic DSM-IV schizophrenia were treated with clozapine or haloperidol decanoate in an open prospective 6-month trial. Changes in measures of suicidality, impulsiveness, aggression, depressed mood, and positive and negative symptoms were assessed at baseline and at 6 months. The clozapine-treated group (N = 18) had a significantly greater reduction on all outcome measures compared with the haloperidol decanoate-treated group (N = 26). Only in the clozapine-treated group did the reduction in measures of suicidality correlate significantly with a reduction in impulsiveness and aggression. The reductions in suicidality and impulsive aggression were not significantly correlated with reductions in depressed mood or positive and negative symptom scores in either group. These data suggest that the reduction in suicidality following long-term clozapine treatment may be related to a reduction in impulsiveness and aggression.


  • The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controls

    by Yaffa Vered, Pavel Golubchik, Tamar Mozes, Rael Strous, Allon Nechmad, Roberto Mester, Abraham Weizman, Baruch Spivak

    There are cumulative data indicating involvement of the 5‐HT system in autistic disorder. Most studies examining 5‐HT function have focused on whole blood 5‐HT content. The carbohydrate‐rich meal test (CRMT) is a dietary manipulation that could significantly influence platelet‐poor plasma (PPP) 5‐HT levels and reflect the responsiveness of the serotonergic system in ‘free’ plasma. In this study, CRMT was used as an indicator of 5‐HT responsivity in drug‐free adults with autistic disorder (n = 7), compared with normal controls (n = 10). The PPP 5‐HT levels were measured at baseline and during 3 h after administration of the CRMT. A significant elevation in PPP 5‐HT levels in adult autistic patients was reached 60 min after meal administration (p < 0.03 vs control and p = 0.05 vs baseline) and a significant decrease was noted after 120 min (p < 0.01 vs baseline). In contrast to the biphasic response of the autistic patients, normal controls exhibited a gradual linear increase of PPP 5‐HT levels. Our results indicate that in adult autistic patients, the pattern of PPP 5‐HT responsivity to a dietary challenge of CRMT is dysregulated compared with normal controls and provide further support for the role of 5‐HT in autism. Copyright © 2003 John Wiley & Sons, Ltd.


  • Plasma Testosterone Levels in Patients with Combat-Related Posttraumatic Stress Disorder

    by Baruch Spivak, Rachel Maayan, Roberto Mester, Abraham Weizman

    Background: An abnormal level of androgens has been reported in various psychiatric disorders and the important role of androgens in the regulation of human sexuality, aggression, cognition, emotions and personality have been described. Previous studies in the area of stress and the hypothalamic-pituitary-gonadal (HPG) system in humans indicate that circulating testosterone levels are suppressed by physical and psychological stress. However, there is also evidence that plasma levels of testosterone can increase during potentially stressful events and may be elevated in combat-related posttraumatic stress disorder (CR-PTSD) in comparison with normal subjects and major depressive disorder patients. Methods: The aim of the present study was to examine the possible involvement of the HPG system in chronic untreated CR-PTSD. To this end, we assessed the morning plasma levels of testosterone and cortisol in never-treated chronic CR-PTSD outpatients compared with normal healthy controls. Results: There were no statistically significant differences between the CR-PTSD patients and healthy control subjects in morning plasma testosterone (547.8 ± 152.2 ng/dl vs. 565.6 ± 122.4 ng/dl; p = 0.7) and cortisol (19.0 ± 8.5 µg/dl vs. 15.4 ± 5.1 µg/dl; p = 0.1) levels. However, a significant correlation between plasma testosterone level and avoidance symptom scores of the Impact of Events Scale (IES) was found in the CR-PTSD patients (r = 0.43, p < 0.05). Conclusions: The findings of plasma testosterone levels comparable with normal controls in CR-PTSD patients may indicate that the previously described reduction in testosterone levels in normal subjects under stressful conditions may reflect the acute stress response of the HPG axis, in contrast to an adaptation of the HPG axis under chronic psychological stress.